Search All UT System Experts

TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

Pavla Brachova, Samuel R. Mueting, Matthew J. Carlson, Michael J. Goodheart, Anna M. Button, Sarah L. Mott, Donghai Dai, Kristina W. Thiel, Eric J. Devor, Kimberly K. Leslie

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences